Creative Planning’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,164
Closed -$386K 3078
2023
Q2
$386K Buy
9,164
+2,844
+45% +$115K ﹤0.01% 1724
2023
Q1
$225K Buy
+6,320
New +$229K ﹤0.01% 2036
2017
Q3
Sell
-200
Closed -$12K 3929
2017
Q2
$12K Sell
200
-345
-63% -$17.9K ﹤0.01% 3538
2017
Q1
$25K Buy
545
+345
+173% +$17.2K ﹤0.01% 2983
2016
Q4
$11K Sell
200
-191
-49% -$9.25K ﹤0.01% 3512
2016
Q3
$17K Buy
391
+191
+96% +$8.28K ﹤0.01% 3181
2016
Q2
$8K Sell
200
-1,200
-86% -$52.7K ﹤0.01% 3416
2016
Q1
$58K Sell
1,400
-87
-6% -$3.59K ﹤0.01% 1995
2015
Q4
$72K Buy
1,487
+487
+49% +$21.7K ﹤0.01% 1834
2015
Q3
$40K Buy
+1,000
New +$43.7K ﹤0.01% 2204
2015
Q2
Sell
-200
Closed -$7K 3229
2015
Q1
$7K Hold
200
﹤0.01% 3414
2014
Q4
$5K Buy
+200
New +$4.76K ﹤0.01% 3521

Other funds holding SYNH

Creative Planning's SYNH Position: Q3 2023 in Review

Creative Planning sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 9,164 shares — an estimated $386K sold.

Creative Planning first reported a position in SYNH in Q4 2014 and held it in 12 quarters. The position peaked at $386K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Creative Planning reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Creative Planning sold 9,164 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $386K.
  • Creative Planning first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 12 quarters.
  • Creative Planning's Syneos Health, Inc. Class A Common Stock position peaked at $386K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.